BCL-2 protein | Subcellular localization | Function | References |
---|---|---|---|
BCL-2 | Consistently linked to the MOM and/or ER membrane | Both apoptosis effectors and BH3 only proteins are inhibited | |
BCL-XL | Located in the nucleus envelope, endoplasmic reticulum (ER), and mitochondrial membrane surfaces | Bind to BAX or BAK to prevent apoptosis | |
MCL-1 | Placement to the outer mitochondrial membrane (OMM), inner mitochondrial membrane (IMM) | BH3-only proteins are inhibited as well as apoptotic effectors. Has an impact on cellular health and development in addition to its known pro-survival activities | [55] |
BCL-W | Loosely connected to the mitochondrial membrane and cytosol | Inhibits BH3-only proteins as well as apoptotic effectors | |
A1/Bfl-1 | Identified on the Golgi apparatus, cytosol, nuclear envelope, and ER membranes | Opposes the activation of caspase and prevents the release of proapoptotic cytochrome c from mitochondria | |
BAK | Always present on the OMM | Oligomerizes to create holes in the OMM, which is considered to enhance MOMP | [57] |
BAX | Present on the OMM, often present in the cytoplasm as an inactive monomer | Oligomerizes to create holes in the OMM, which is considered to enhance MOMP | [57] |
BOK | Detected on the ER membranes, nuclear outer membrane, and Golgi apparatus | Depends on BAX and BAK to promote apoptosis | [58] |
BAD | Both the cytosol and the mitochondrial membrane | BAD is referred to as a "indirect" promoter of apoptosis because it causes cell death through inhibiting antiapoptotic proteins | [59] |
BIM | Nucleus envelope, endoplasmic reticulum (ER), cytoplasm, and mitochondrial outer membrane (MOM) | Apoptotic induction, it also controls mitochondrial activity and cellular metabolism | |
PUMA | Placement on the mitochondrial outer membrane (MOM) | Crucial p53-dependent apoptosis mediator. Activates BAK and BAX, resulting in MOMP | |
BIK | Mostly found in the ER membrane | Directly impacts BCL-2 and BCL-2-like 1 |